Sun Pharmaceutical Industries Share Price Today - Live Blog for October 27, 2025

After a significant 0.12% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,695.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.09% slump and is currently trading at ₹1,693.55. While the stock maintains a PE ratio of 39.2200, the industry PE is 34.9088, raising questions about valuation.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.02% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,695.45, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd shares saw a -0.07% decrease, reaching a current market price of ₹1,693.75. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 39.2200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Demonstrating a commendable 0.01% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,695.70. In terms of valuation, the stock maintains a PE ratio of 39.2200, while the industry PE ratio stands at 34.9088.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.02% recently. As of now, this stock is actively trading at a current market price of ₹1,695.40 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd showed no price shifts, holding steady at ₹1,695.00. While the stock's performance remains consistent, it's worth noting that its PE ratio is 39.2200, while the industry PE is 34.9088.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.22% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,695.30, making it an appealing option for investors.

After a significant 0.22% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,695.30 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.01%, and it is currently trading at ₹1,690.60. Additionally, the stock maintains a PE ratio of 39.2200, while the industry PE is 34.9088.

After a significant 0.01% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,690.60 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.16% drop, and it's now trading at ₹1,690.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,692.05. The stock has a PE ratio of 39.2200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.01% upswing and is currently trading at ₹1,693.00, indicating strong market sentiment.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.06% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,694.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,692.90. The stock has a PE ratio of 39.2200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price remained unchanged, indicating a period of stability in the market. As of now, the stock is still trading at ₹1,695.00. This static phase might encourage investors to assess their long-term strategies.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.13% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,696.30 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.04% drop in its share price and is currently trading at ₹1,694.75. With the stock's PE at 39.2200 and the industry PE at 34.9088, investors are weighing their options.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.05% upswing and is currently trading at ₹1,696.50, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.13% surge in its share price and is presently trading at ₹1,695.70. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.01% surge in its share price and is presently trading at ₹1,693.45. The increased investor interest is driving this surge.

Following a noteworthy 0.01% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,693.25. When it comes to valuation, this stock has a PE ratio of 39.2200, with the industry PE ratio at 34.9088.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.24% drop, and it's now trading at ₹1,692.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.13% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,695.20. Investors should examine the factors driving this decline. The stock's PE ratio is 39.2200, whereas the industry PE ratio stands at 34.9088.

After a notable 0.05% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,695.25. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd shares saw a -0.29% decrease, reaching a current market price of ₹1,694.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 39.2200, an ROE of 15.1334% and a debt to equity ratio of 0.0327.